I1DX34.SA
IDEXX Laboratories, Inc. News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 3,
"returned": 3,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "148d55d9-17c3-4c12-98e2-41e93826b295",
"title": "IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript",
"description": "IDEXX Laboratories, Inc. beats earnings expectations. Reported EPS is $2.81, expectations were $2.7.",
"keywords": "",
"snippet": "IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript May 1, 2024\n\nIDEXX Laboratories, Inc. beats earnings expectations. Reported EPS is $2.81...",
"url": "https://www.insidermonkey.com/blog/idexx-laboratories-inc-nasdaqidxx-q1-2024-earnings-call-transcript-1295555/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/28095342/IDXX-insidermonkey-1695909219639.jpg",
"language": "en",
"published_at": "2024-05-02T18:22:21.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "I1DX34.SA",
"name": "IDEXX Laboratories, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 159.85565,
"sentiment_score": 0.422625,
"highlights": [
{
"highlight": "<em>IDEXX</em> <em>Laboratories</em>, <em>Inc</em>. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript May 1, 2024\n\n<em>IDEXX</em> <em>Laboratories</em>, <em>Inc</em>. beats earnings expectations. Reported EPS is $2.81, expectations were $2.7. IDXX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).",
"sentiment": 0.4703,
"highlighted_in": "main_text"
},
{
"highlight": "Operator: Good morning and welcome to the <em>IDEXX</em> <em>Laboratories</em> First Quarter 2024 Earnings Conference Call. As a reminder, today’s conference is being recorded. Participating in the call this morning are Jay Mazelsky, President and Chief Executive Officer; Brian McKeon, Chief Financial Officer; and John Ravis, Vice President, Investor Relations.",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Q&A Session\n\nFollow <em>Idexx</em> <em>Laboratories</em> <em>Inc</em> (NASDAQ:IDXX) Follow <em>Idexx</em> <em>Laboratories</em> <em>Inc</em> (NASDAQ:IDXX) or Subscribe with Google We may use your email to send marketing emails about our services. Click here to read our privacy policy.\n\nBuilding on our strong first quarter performance, we’re reinforcing our operational EPS outlook at midpoint.",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "<em>IDEXX</em> <em>Laboratories</em>, <em>Inc</em>. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "84a3c0eb-361d-46fb-9823-d017c0306990",
"title": "IDEXX Laboratories Inc (IDXX) (Q1 2024) Earnings Call Transcript Highlights: Key Financial Metrics and Strategic Insights",
"description": "Organic Revenue Growth: 7% increase, with CAG Diagnostic recurring revenues also up 7%.Earnings Per Share (EPS): $2.81, up 10% as reported, 9% on a comparable",
"keywords": "GuruFocus, Article, News, GuruFocus Research, IDXX",
"snippet": "Release Date: May 01, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nPositive Points\n\nIDEXX Laborat...",
"url": "https://www.gurufocus.com/news/2424770/idexx-laboratories-inc-idxx-q1-2024-earnings-call-transcript-highlights-key-financial-metrics-and-strategic-insights",
"image_url": "https://static.gurufocus.com/logos/0C00000BE9.png?5",
"language": "en",
"published_at": "2024-05-02T07:08:27.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "I1DX34.SA",
"name": "IDEXX Laboratories, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 126.86996,
"sentiment_score": 0.6319,
"highlights": [
{
"highlight": "Positive Points\n\n<em>IDEXX</em> <em>Laboratories</em> <em>Inc</em> (IDXX, Financial) reported a solid 7% organic revenue growth in Q1, driven by strong performance in CAG Diagnostic recurring revenues and veterinary software.\n\nProfit delivery was robust, supported by gross margin gains, with EPS increasing by 10% as reported and 9% on a comparable basis.",
"sentiment": 0.9432,
"highlighted_in": "main_text"
},
{
"highlight": "<em>IDEXX</em> <em>Laboratories</em> <em>Inc</em> (IDXX) saw an 8% increase in global premium instrument placements, indicating strong execution and market demand.\n\nThe company achieved 11% organic growth in its Water business, showcasing diversification and strength beyond its core veterinary segments.",
"sentiment": 0.872,
"highlighted_in": "main_text"
},
{
"highlight": "<em>IDEXX</em> <em>Laboratories</em> <em>Inc</em> (IDXX) maintained a strong balance sheet with healthy leverage ratios, allowing for continued strategic investments and share repurchases.",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "<em>IDEXX</em> <em>Laboratories</em> <em>Inc</em> (IDXX) adjusted the high end of its full-year organic growth outlook due to ongoing staffing challenges at veterinary clinics and broader macroeconomic pressures affecting consumer behavior.\n\nForeign exchange fluctuations posed challenges, necessitating adjustments in financial outlook and impacting EPS growth projections.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>IDEXX</em> <em>Laboratories</em> <em>Inc</em> (IDXX) (Q1 2024) Earnings Call Transcript Highlights: Key Financial Metrics and Strategic Insights",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "cc71edf3-e7b9-4900-ad3b-a1e84c4ccd50",
"title": "Q1 2024 IDEXX Laboratories Inc Earnings Call Transcript",
"description": "May 01, 2024 / 12:30PM GMTOperator Good morning, and welcome to the IDEXX Laboratories First Quarter 2024 Earnings Conference Call. As a reminder, today's confe",
"keywords": "GuruFocus, Article, News, GuruFocus Research, NAS:IDXX",
"snippet": "May 01, 2024 / 12:30PM GMT\n\nOperator\n\n\n\nGood morning, and welcome to the IDEXX Laboratories First Quarter 2024 Earnings Conference Call. As a reminder, today's ...",
"url": "https://www.gurufocus.com/news/2424515/q1-2024-idexx-laboratories-inc-earnings-call-transcript",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2024-05-02T05:14:19.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "I1DX34.SA",
"name": "IDEXX Laboratories, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 165.89067,
"sentiment_score": 0.3548,
"highlights": [
{
"highlight": "May 01, 2024 / 12:30PM GMT\n\nOperator\n\n\n\nGood morning, and welcome to the <em>IDEXX</em> <em>Laboratories</em> First Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded.",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Q1 2024 <em>IDEXX</em> <em>Laboratories</em> <em>Inc</em> Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "I1DX34.SA",
"total_documents": 3,
"sentiment_avg": 0.4697750012079875
}
]
}
Other details
Exchange
- The B3 S.A. - Brasil, Bolsa, Balcão
- equity
- Healthcare
- br